Levemir Unió Europea - anglès - EMA (European Medicines Agency)

levemir

novo nordisk a/s - insulin detemir - diabetes mellitus - drugs used in diabetes - treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.

TRULICITY dulaglutide (rch) 1.5 mg/0.5 mL solution for injection prefilled syringe Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

trulicity dulaglutide (rch) 1.5 mg/0.5 ml solution for injection prefilled syringe

eli lilly australia pty ltd - dulaglutide -

Trulicity Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

trulicity

eli lilly and company (nz) limited - dulaglutide 3 mg/ml - solution for injection - 1.5 mg/0.5ml - active: dulaglutide 3 mg/ml excipient: citric acid mannitol polysorbate 80 sodium citrate dihydrate water for injection - type 2 diabetes mellitus: glycaemic control: trulicity is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus: o as monotherapy. o in combination with other glucose-lowering medicinal products including insulin, when these, together with diet and exercise, do not provide adequate glycaemic control (see section 5.1 for data with respect to different combinations). type 2 diabetes mellitus: reduction in risk of major adverse cardiovascular events: trulicity is indicated as an adjunct to standard of care therapy to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes mellitus who have: o established cardiovascular disease or o multiple cardiovascular risk factors

Trulicity 0.75mg0.5ml solution for injection pre-filled pen Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

trulicity 0.75mg0.5ml solution for injection pre-filled pen

eli lilly and company ltd - dulaglutide - solution for injection - 1.5mg/1ml

Trulicity 1.5mg0.5ml solution for injection pre-filled pen Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

trulicity 1.5mg0.5ml solution for injection pre-filled pen

eli lilly and company ltd - dulaglutide - solution for injection - 3mg/1ml

Trulicity 0.75mg solution for injection in pre-filled pen Malàisia - anglès - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

trulicity 0.75mg solution for injection in pre-filled pen

zuellig pharma sdn bhd - dulaglutide -

LYXUMIA SOLUTION FOR INJECTION IN PRE-FILLED PEN 10MCG (50mcgmL) Singapur - anglès - HSA (Health Sciences Authority)

lyxumia solution for injection in pre-filled pen 10mcg (50mcgml)

sanofi-aventis singapore pte. ltd. - lixisenatide - injection, solution - 50mcg/ml - lixisenatide 50mcg/ml

LYXUMIA SOLUTION FOR INJECTION IN PRE-FILLED PEN 10MCG AND 20MCG (50mcgmL and 100mcgmL) Singapur - anglès - HSA (Health Sciences Authority)

lyxumia solution for injection in pre-filled pen 10mcg and 20mcg (50mcgml and 100mcgml)

sanofi-aventis singapore pte. ltd. - (10mcg) lixisenatide; (20mcg) lixisenatide - injection, solution - 0.05mg/ml - (10mcg) lixisenatide 0.05mg/ml; (20mcg) lixisenatide 0.1mg/ml

LYXUMIA SOLUTION FOR INJECTION IN PRE-FILLED PEN 20MCG (100mcgmL) Singapur - anglès - HSA (Health Sciences Authority)

lyxumia solution for injection in pre-filled pen 20mcg (100mcgml)

sanofi-aventis singapore pte. ltd. - lixisenatide - injection, solution - 100mcg/ml - lixisenatide 100mcg/ml

LEVEMIR FLEXPEN insulin detemir (rys) 100 U/mL injection cartridge Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

levemir flexpen insulin detemir (rys) 100 u/ml injection cartridge

novo nordisk pharmaceuticals pty ltd - insulin detemir, quantity: 100 u/ml - injection, solution - excipient ingredients: glycerol; sodium hydroxide; dibasic sodium phosphate dihydrate; water for injections; hydrochloric acid; zinc acetate; metacresol; phenol; sodium chloride - treatment of diabetes mellitus. (see 'pharmacology' and 'clinical trials.')